Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness.
Where this comes from
- Record sourced from PubMed, PMID 34550323.
- Also identified by DOI 10.1001/jamapsychiatry.2021.2503 and PMC identifier 8459305.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study investigates whether an association exists between antipsychotic use and mortality in patients with serious mental illness who are diagnosed with COVID-19.
Medical subject headings
- Antipsychotic Agents
- Bipolar Disorder
- COVID-19
- Schizophrenia